Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony R Mato

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
PET Clinics|May 16, 2019
PET/Computed Tomography in Chronic Lymphocytic Leukemia and Richter TransformationJoanna M Rhodes, Anthony R Mato
Hematology/Oncology Clinics of North America|June 27, 2021
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton's Tyrosine Kinase InhibitorsMeghan C Thompson, Anthony R Mato
Hematology. American Society of Hematology. Education Program|December 4, 2020
Approaches for relapsed CLL after chemotherapy-free frontline regimensLindsey E Roeker, Anthony R Mato
The Oncologist|May 9, 2012
Proteasome inhibition and combination therapy for non-Hodgkin's lymphoma: from bench to bedsideAnthony R Mato, Tatyana Feldman, André Goy
Current Opinion in Hematology|February 28, 2008
Novel strategies for relapsed and refractory acute myeloid leukemiaAnthony R Mato, Alicia Morgans, Selina M Luger
Drugs|December 21, 2021
Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of ChemoimmunotherapyLindsey E Roeker, Meghan Thompson, Anthony R Mato
Blood|November 16, 2018
Combinations or sequences of targeted agents in CLL: is the whole greater than the sum of its parts (Aristotle, 360 BC)?Maryam Sarraf Yazdy, Anthony R Mato, Bruce D Cheson
JAMA Oncology|July 21, 2017
Biosimilars in Oncology in the United States: A ReviewChadi Nabhan, Sandeep Parsad, Anthony R Mato, et al.
PET Clinics|June 21, 2016
Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET ImagingEmily C Ayers, Sara Fardin, Saeid Gholami, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Approaches to Chronic Lymphocytic Leukemia Therapy in the Era of New Agents: The Conundrum of Many OptionsNitin Jain, Philip Thompson, Alessandra Ferrajoli, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
PET Clinics|May 16, 2019
PET/Computed Tomography in Chronic Lymphocytic Leukemia and Richter TransformationJoanna M Rhodes, Anthony R Mato
Hematology/Oncology Clinics of North America|June 27, 2021
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton's Tyrosine Kinase InhibitorsMeghan C Thompson, Anthony R Mato
Hematology. American Society of Hematology. Education Program|December 4, 2020
Approaches for relapsed CLL after chemotherapy-free frontline regimensLindsey E Roeker, Anthony R Mato
The Oncologist|May 9, 2012
Proteasome inhibition and combination therapy for non-Hodgkin's lymphoma: from bench to bedsideAnthony R Mato, Tatyana Feldman, André Goy
Current Opinion in Hematology|February 28, 2008
Novel strategies for relapsed and refractory acute myeloid leukemiaAnthony R Mato, Alicia Morgans, Selina M Luger
Drugs|December 21, 2021
Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of ChemoimmunotherapyLindsey E Roeker, Meghan Thompson, Anthony R Mato
Blood|November 16, 2018
Combinations or sequences of targeted agents in CLL: is the whole greater than the sum of its parts (Aristotle, 360 BC)?Maryam Sarraf Yazdy, Anthony R Mato, Bruce D Cheson
JAMA Oncology|July 21, 2017
Biosimilars in Oncology in the United States: A ReviewChadi Nabhan, Sandeep Parsad, Anthony R Mato, et al.
PET Clinics|June 21, 2016
Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET ImagingEmily C Ayers, Sara Fardin, Saeid Gholami, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Approaches to Chronic Lymphocytic Leukemia Therapy in the Era of New Agents: The Conundrum of Many OptionsNitin Jain, Philip Thompson, Alessandra Ferrajoli, et al.
Pageof 10